Immediate Impact
2 by Nobel laureates 60 standout
Citing Papers
Bispecific and multispecific antibodies in oncology: opportunities and challenges
2024 Standout
Deciphering the spatial landscape and plasticity of immunosuppressive fibroblasts in breast cancer
2024 Standout
Works of Oliver Krieter being referenced
1025MO First-in-human (FIH) phase I study of RO7122290 (RO), a novel FAP-targeted 4-1BB agonist, administered as single agent and in combination with atezolizumab (ATZ) to patients with advanced solid tumours
2020
Vanucizumab mode of action: Serial biomarkers in plasma, tumor, and skin-wound-healing biopsies
2020
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| Oliver Krieter | 110 | 134 | 44 | 51 | 25 | 205 | |
| Cath Eberlein | 80 | 160 | 21 | 28 | 17 | 252 | |
| Stephanie Royer‐Joo | 133 | 179 | 32 | 51 | 22 | 285 | |
| Jing Christine Ye | 130 | 83 | 44 | 55 | 19 | 236 | |
| Zhen Wang | 110 | 206 | 26 | 38 | 23 | 293 | |
| Dina Sakaeva | 155 | 88 | 32 | 27 | 43 | 248 | |
| Leiming Xia | 71 | 136 | 12 | 65 | 32 | 272 | |
| Johanne Lade‐Keller | 191 | 166 | 12 | 63 | 17 | 296 | |
| Cheng‐Hao Chuang | 97 | 120 | 17 | 32 | 17 | 252 | |
| Dionysis Papadatos-Pastos | 97 | 129 | 36 | 14 | 20 | 266 | |
| Giuliana Pavone | 100 | 123 | 12 | 17 | 17 | 257 |
All Works
Login with ORCID to disown or claim papers
Loading papers...